On November 2, 2017 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, reported that it will present at the following upcoming healthcare conferences in November (Press release, Intellia Therapeutics, NOV 2, 2017, View Source [SID1234521516]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Tuesday, November 7, 2017
Credit Suisse 26th Annual Healthcare Conference
Who: Tom Barnes, Ph.D., Senior Vice President, Innovation Sciences
Location: Scottsdale, Arizona
Presentation Time: 9:45am MST (11:45am EST)
Wednesday, November 15, 2017
Jefferies London Healthcare Conference
Who: John Leonard, M.D., Executive Vice President, R&D
Location: London, United Kingdom
Presentation Time: 8:40am GMT (2:40am EST)
Thursday, November 30, 2017
Barclays Gene Editing/Therapy Summit
Who: Nessan Bermingham, Ph.D., Chief Executive Officer and Founder
Location: New York, New York
Presentation Time: 1:40pm EST
A live webcast of Intellia’s presentations will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for 14 days following each conference.